IPO - Rhythm Biosciences Limited, page-134

Why don't you come up with some surveys regarding the sampling preference? Even if one preferred a blood test over a stool sample they more than likely will decide to not take the test because of poor knowledge regarding risk and the importance of early detection. You're talking as if the RHY has already been fully scientifically validated and adopted in a few thousand clinics. It's quite a while from that point; a bit worse than the old coin flip really. I guess if the product ever reaches the market, one will see whether the nature of the test stimulates any meaningful uptake and no... I'm not anywhere near that old, nor do I have any of the risk factors to have such a test done yet.

Haha. People who are not part of the field of healthcare do not adequately understand patients and the industry in general. They'll buy into hype, only to get burnt later on.

DYOR.